Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Healthy Extracts (HYEX) Change in Receivables (2016 - 2025)

Healthy Extracts (HYEX) has 11 years of Change in Receivables data on record, last reported at $27284.0 in Q3 2025.

  • For Q3 2025, Change in Receivables rose 138.54% year-over-year to $27284.0; the TTM value through Sep 2025 reached $11498.0, up 112.85%, while the annual FY2024 figure was -$19437.0, 74.21% up from the prior year.
  • Change in Receivables reached $27284.0 in Q3 2025 per HYEX's latest filing, up from -$66001.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $97351.0 in Q3 2021 and bottomed at -$78783.0 in Q4 2023.
  • Average Change in Receivables over 5 years is $946.79, with a median of -$6385.0 recorded in 2024.
  • Peak YoY movement for Change in Receivables: tumbled 1663.78% in 2023, then soared 1023.68% in 2025.
  • A 5-year view of Change in Receivables shows it stood at $49755.0 in 2021, then plummeted by 89.87% to $5038.0 in 2022, then crashed by 1663.78% to -$78783.0 in 2023, then surged by 88.88% to -$8762.0 in 2024, then skyrocketed by 411.39% to $27284.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Receivables were $27284.0 in Q3 2025, -$66001.0 in Q2 2025, and $58977.0 in Q1 2025.